A LinkedIn post from Credo AI highlights the growing deployment of AI in healthcare and the associated need for enforceable governance. The post cites CEO Navrina Singh emphasizing that healthcare requires “agentic” AI systems capable of making governance auditable and continuous, rather than purely policy-based.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, Credo AI has joined the Coalition for Health AI (CHAI) Partner Program to support governance in what it describes as a complex, high‑stakes compliance environment. The company’s platform is presented as operationalizing CHAI’s framework through a healthcare-focused policy pack aligned with regulations including HIPAA, ONC HT-1, ISO 42001, and guidance from The Joint Commission.
The post suggests this approach is intended to give healthcare organizations a unified view of overlapping regulatory obligations across AI models, vendors, and use cases. For investors, this alignment with CHAI and emphasis on agentic AI governance could position Credo AI to capture demand from health systems and life sciences firms seeking scalable compliance solutions, potentially strengthening its role in the emerging healthcare AI infrastructure stack.